CellSeed Inc (7776):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CellSeed Inc (7776) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8067
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CellSeed Inc (CellSeed) is a developer of regenerative medicine. The company’s products include epithelial cell sheet for corneal regeneration, regenerated cardiac patch, epithelial cell sheet for esophageal regeneration, cell sheet for periodontal tissue regeneration and regenerated cartilage sheet. It provides temperature-responsive cell cultureware for cell-sheet engineering, cell cutureware for cell collection and low cell binding cultureware. CellSeed’s UpCell finds application in tissue culture for regenerative medicine and for construction of 3D tissue. The company’s RepCell finds application in harvesting fragile cells such as stem cells and dendritic cells, and others. It also offers contract development and contract manufacturing services. The company has operations in Japan and Sweden. CellSeed is headquartered in Tokyo City, Japan.

CellSeed Inc (7776) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CellSeed Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CellSeed Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CellSeed Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Xintela Enters into Collaboration Agreement with CellSeed 10
Licensing Agreements 11
Emmaus Medical Enters into Licensing Agreement with CellSeed 11
Equity Offering 12
CellSeed Completes IPO For US$39 Million 12
CellSeed Inc – Key Competitors 13
CellSeed Inc – Key Employees 14
CellSeed Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
CellSeed Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CellSeed Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CellSeed Inc, Deals By Therapy Area, 2012 to YTD 2018 8
CellSeed Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Xintela Enters into Collaboration Agreement with CellSeed 10
Emmaus Medical Enters into Licensing Agreement with CellSeed 11
CellSeed Completes IPO For US$39 Million 12
CellSeed Inc, Key Competitors 13
CellSeed Inc, Key Employees 14
CellSeed Inc, Subsidiaries 15

List of Figures
CellSeed Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CellSeed Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CellSeed Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CellSeed Inc (7776):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lincoln Electric Cooperative Inc:企業の戦略的SWOT分析
    Lincoln Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Viterra Inc.:企業のM&A・事業提携・投資動向
    Viterra Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Viterra Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Tohoku Electric Power Company, Incorporated:企業の戦略・SWOT・財務分析
    Tohoku Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Tohoku Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Bandera Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Bandera Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Frequency Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Frequency Therapeutics Inc (Frequency Therapeutics) is a biotechnology company that develops progenitor cell activation (PCA) therapies. The company’s small molecule drugs are used to activate progenitor cells for restoration of healthy tissue. Its lead program FX-322 is used to recreate sen …
  • Life Time Inc:企業の戦略的SWOT分析
    Life Time Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Extendicare Inc.:企業の戦略・SWOT・財務情報
    Extendicare Inc. - Strategy, SWOT and Corporate Finance Report Summary Extendicare Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kallpa Generacion SA:企業の戦略的SWOT分析
    Kallpa Generacion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • RigNet Inc (RNET):企業の財務・戦略的SWOT分析
    RigNet Inc (RNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Duke Energy Indiana LLC:企業の戦略的SWOT分析
    Duke Energy Indiana LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Novant Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Novant Health Inc (Novant Health) is a not-for-profit, integrated healthcare service provider. The organization provides services related to assisted living, blood services, breast health, children’s services, laboratory services, emergency, laboratory services, cancer, urgent care, hospice …
  • Fonar Corp (FONR):企業の財務・戦略的SWOT分析
    Summary Fonar Corp (Fonar) is a medical device company that develops and manufacturers magnetic resonance imaging (MRI) scanners. The company provides products such as upright MRI, Fonar 360 and the open sky MRI. Fonar upright MRI is equipped with its MRI–compatible motorized patient handling system …
  • BoneSupport AB:企業の戦略的SWOT分析
    BoneSupport AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Chevron Corp (CVX):企業の財務・戦略的SWOT分析
    Chevron Corp (CVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Demant AS (DEMANT):企業の財務・戦略的SWOT分析
    Demant AS (DEMANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Bank Leumi le-Israel B.M.:戦略・SWOT・企業財務分析
    Bank Leumi le-Israel B.M. - Strategy, SWOT and Corporate Finance Report Summary Bank Leumi le-Israel B.M. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Oi S.A.:企業の戦略・SWOT・財務情報
    Oi S.A. - Strategy, SWOT and Corporate Finance Report Summary Oi S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Rada Electronic Industries Ltd.
    Rada Electronic Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Rada Electronic Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Tampa Electric Co:企業の戦略的SWOT分析
    Tampa Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Coloplast AS (COLO B):医療機器:M&Aディール及び事業提携情報
    Summary Coloplast A/S (Coloplast) is a medical device company that offers products and services for ostomy care, urology care, continence care, and skin and wound care. Its major products include ostomy bags; urisheaths; urine bags; catheters; anal irrigation systems; vaginal sling products; advance …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆